Metabolic risk factors of coronary heart disease in relation to anthropometric measures in nonalcoholic fatty liver disease patients following dietary intervention

Małgorzata Kaczorowska, Karina Ryterska, Piotr Ossowski, Dominika Maciejewska, Anna Sabinicz, Dominika Jamioł-Milc, Joanna Raszeja-Wyszomirska, Ewa Stachowska


Introduction: Nonalcoholic fatty liver disease (NAFLD) is connected with high risk of metabolic disorders, such as: metabolic syndrome, type 2 diabetes, dyslipidemia and independently, coronary heart disease (CHD).

Materials and methods: A group of 108 Caucasian individuals (39 women and 69 men) aged 20–77 years with NAFLD were prospectively enrolled in the study. The diagnosis of NAFLD was confirmed during the first appointment using ultrasonography. The liver serum tests such as alanine aminotransferase and aspartate aminotransferase levels were taken into account, as well. All of the tests and measurements were taken at the begining and after 6 month of dieting. Anthropometric tools (body mass index – BMI, waist circumference – WC, waist to hip ratio – WHR, waist to height ratio – WHtR, coinicity index – C -Index) were examined in relation to metabolic risk factors of CHD (increased: triacylglycerols, low density lipoprotein, total cholesterol, glycemia and low high density lipoprotein).

Results: Statistical significant reduction of body weight, BMI, WC, WHR, WHtR and C -Index (p < 0.05) contributed to the improvement of serum triacylglycerols in both sexes (p < 0.05). Indicators of abdominal obesity (WC, WHR, WHtR, C -Index) correlated significantly with serum glucose (p < 0.05) both before and after the diet and with serum lipids, either before or after the diet (p < 0.05), in both sexes. Conclusions: It seems beneϐicial to spread the use of anthropometric tools, especially C -Index and WHtR, in primary health care practice for either early prevention or prediction of metabolic CHD risk occurrence, and its potential fatal consequences among patients with NAFLD or with other metabolic disorders.


e; risk factors; anthropometry; nutrition; metabolic syndrome

Full Text:



Yki -Jarvinen H. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr Opin Clin Nutr Metab Care 2010;13:709 -14.

Yki -Jarvinen H. Non -alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014;2(11):901 -10.

Blachier M, Leleu H, Peck -Radosavljevic M, Valla DC, Roudot -Thoraval F. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol 2013;58:593 -608.

Valantinas J, Apanaviciene DA, Maroziene L, Sveikata A. The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liverdisease in Lithuania. Med Sci Monit 2012;18:57 -62.

Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 2011;34:1114-39.

Zelber -Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011;17:3377 -89.

Conlon BA, Beasley JM, Aebersold K, Jhangiani SS, Wylie Rosett J. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients 2013;5:4093 -114.

Walenbergh SM, Koek GH, Bieghs V, Shiri -Sverdlov R. Non -alcoholic steatohepatitis: the role of oxidized low density lipoproteins. J Hepatol 2013;58:801 -10.

Fan JG, Cao HX. Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2013;28 Suppl 4:81 -7.

Ueno T, Sugawara H, Sujuku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercises in obese patients with fatty liver. J Hepatol 1997;27:103-7.

Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the espghan hepatology committee. J Pediatr Gastroenterol Nutr 2012;54:700-13.

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among U.S. children and adolescents. 1999–2010. JAMA 2012;307:483 90.

Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;3 -4:155 -78.

Ding D, Li X, Qiu J, Li R, Zhang Y, Su D, et al. Serum lipids, apolipoproteins and mortality among coronary artery disease patients. Biomed Res Int 2014;2014:709756. doi: 10.1155/2014/709756.

Kannel WB, McGee D, Gordon T. A general cardiovascular risk proϐile: the Framingham Study. Am J Cardiol 1976;38:46 -51.

Menotti A, Keys A, Blackburn H, Kromhout D, Karvonen M, Nissinen A, et al. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25 -year follow -up. J Cardiovasc Risk 1996;1:69 -75.

Rose G, Hamilton PS, Keen H, Reid DD, McCartney P, Jarrett RJ. Myocardialischaemia risk factors and death from coronary heart disease. Lancet 1977;1:105 -9.

Ko DT, Wijeysundera HC, Udell JA, Vaccarino V, Austin PC, Guo H, et al. Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease inmen and women. Can J Cardiol 2014;30:820 -6.

Logstrup S, editor. European Cardiovascular Disease Statistics 2008 edition. Brussels: European Heart Network; 2008.

Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;12:1231 -48.

Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization; 2000. p 5 -13.

Kannel WB, Wilson PW, Nam BH, D’Agostino RB. Riskstratification of obesity as a coronary risk factor. Am J Cardiol 2002;90:697 -701.

Tonstad S. Hjermann I. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40 -year -old men and women. J Cardiovasc Risk 2003;10:129 -35.

Almeida RT, Almeida MM, Araujo TM. Abdominal obesity and cardiovascular risk: Performance of anthropometric indexes in women. Arq Bras Cardiol 2009;92:345 -50.

Haun DR, Pitanga FJ, Lessa I. Waist/height ratio compared with other anthropometric indicators of obesity as a predictor of high coronary risk. Rev Assoc Med Bras 2010;56:705 -11.

Shields M, Tremblay MS, Connor Gorber S, Janssen I. Abdominal obesity and cardiovascular disease risk factors within body mass index categories. Health Rep 2012;23:7 -15.

Ashwell M, Hsieh SD. Six reasons why the waist -to height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;56:303 -7.

Lemos -Santos MGF, Valente JG, Gonçalves -Silva RM, Sichieri R. Waist circumference and waist -to -hip ratio as predictors of serum concentration of lipids in Brazilian men. Nutrition 2004;20:857 -62.

Kunachowicz H, Nadolna I, Iwanow K. Wartość odżywcza produktów spożywczych i typowych potraw. Warszawa: PZWL; 2001.

Okosun IS, Choi ST, Boltri JM, Parish DC, Chandra KM, Dever GE, et al. Trends of abdominal adiposity in White,

Black, and Mexican-American adults. 1988 to 2000. Obes Res 2003;11:1010 -7.

Perazzo H, Poynard T, Dufour JF. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. Clin Liver Dis 2014;18:233 -48.


Copyright (c) 2016

License URL: